Ibrutinib in B-cell lymphoma: single fighter might be enough?

Abstract Background In recent years, the B cell receptor (BCR) signaling pathway has become a “hot point” because it plays a critical role in B-cell proliferation and function. Bruton’s tyrosine kinase (BTK) is overexpressed in many subtypes of B-cell lymphoma as a downstream kinase in the BCR signa...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Chao Xue, Xin Wang, Lingyan Zhang, Qingyuan Qu, Qian Zhang, Yujie Jiang
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2020-09-01
Цуврал:	Cancer Cell International
Нөхцлүүд:	B-cell lymphoma B cell receptor (BCR) signaling pathway Bruton’s tyrosine kinase (BTK) Ibrutinib Monotherapy
Онлайн хандалт:	http://link.springer.com/article/10.1186/s12935-020-01518-y
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!